<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/197</identifier>
				<datestamp>2024-10-30T19:15:57Z</datestamp>
				<setSpec>aavptbiennial:S3</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Clinical and Experimental Studies with Verapamil in the Dog</dc:title>
	<dc:creator xml:lang="en">Hamlin, Robert L.</dc:creator>
	<dc:subject xml:lang="en">calcium channel blockers</dc:subject>
	<dc:subject xml:lang="en">dogs</dc:subject>
	<dc:subject xml:lang="en">oral administration</dc:subject>
	<dc:subject xml:lang="en">verapamil</dc:subject>
	<dc:subject xml:lang="en">myocardial contractility</dc:subject>
	<dc:subject xml:lang="en">heart rate</dc:subject>
	<dc:subject xml:lang="en">atrial tachycardia</dc:subject>
	<dc:subject xml:lang="en">atrial fibrillation</dc:subject>
	<dc:description xml:lang="en">Calcium channel blockers have been used with increasing frequency in human medicine as antihypertensivies, antianginals, antiarrhythmics, and to treat hypertrophic cardiomyopathy (1). Although many studies have been conducted using dogs as experimental animals being given calcium channel blockers parenterally (2), the primary use in veterinary medicine will probably require administration of these agents by the oral route. Because little information is available describing the effects of verapamil--the most commonly used calcium channel blocker--on myocardial contractility and heart rate, and determining time from administration orally to peak effect and duration of effect (3), this study was conducted on healthy, chronically-instrumented dogs. Parallel with these studies, 27 dogs afflicted with either atrial tachycardia or atrial fibrillation with rapid response, were given verapamil as therapy.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/197</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 89-96</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/197/187</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
